INKON Life Technology Co Ltd
SZSE:300143
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
INKON Life Technology Co Ltd
Net Income (Common)
INKON Life Technology Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
INKON Life Technology Co Ltd
SZSE:300143
|
Net Income (Common)
¥68.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
21%
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Net Income (Common)
¥3.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
22%
|
|
|
I
|
Innovative Medical Management Co Ltd
SZSE:002173
|
Net Income (Common)
-¥61.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
44%
|
CAGR 10-Years
-7%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Net Income (Common)
-¥335.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Net Income (Common)
¥428.6m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Net Income (Common)
¥105m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
INKON Life Technology Co Ltd
Glance View
INKON Life Technology Co., Ltd. engages in the research, development, production and sale of edible fungus. The company is headquartered in Qingdao, Shandong and currently employs 1,791 full-time employees. The company went IPO on 2011-04-22. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The firm is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The firm distributes its products within domestic market and to overseas markets.
See Also
What is INKON Life Technology Co Ltd's Net Income (Common)?
Net Income (Common)
68.5m
CNY
Based on the financial report for Dec 31, 2025, INKON Life Technology Co Ltd's Net Income (Common) amounts to 68.5m CNY.
What is INKON Life Technology Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
21%
Over the last year, the Net Income (Common) growth was -41%.
